STOCK TITAN

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Sage Therapeutics to host webcast to review Q3 2023 financial results and business updates
Positive
  • Sage Therapeutics will host a live webcast to review its third quarter 2023 financial results and discuss recent business updates. The webcast can be accessed on the Investor page of Sage’s website.
Negative
  • None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Investor Contact

Ashley Kaplowitz

786-252-1419

ashley.kaplowitz@sagerx.com



Media Contact

Matthew Henson

917-930-7147

matthew.henson@sagerx.com

Source: Sage Therapeutics, Inc.

FAQ

When will Sage Therapeutics host the webcast?

Sage Therapeutics will host the webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET.

Where can the webcast be accessed?

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com.

Will there be a replay of the webcast?

Yes, a replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

Sage Therapeutics, Inc

NASDAQ:SAGE

SAGE Rankings

SAGE Latest News

SAGE Stock Data

305.87M
53.88M
11.92%
86.51%
10.48%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CAMBRIDGE